missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ GM-CSF Antibody (otilimab), Novus Biologicals™
Human Monoclonal Antibody
£162.00 - £695.00
Specifications
| Antigen | GM-CSF |
|---|---|
| Clone | otilimab |
| Applications | Flow Cytometry, ELISA, Functional Assay |
| Classification | Monoclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
30045963
|
Novus Biologicals™
NBP3-28866-100ug |
100 μg |
£266.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30048186
|
Novus Biologicals™
NBP3-28866-1mg |
1 mg |
£695.00
1mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30048607
|
Novus Biologicals™
NBP3-28866-50ug |
50 μg |
£162.00
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
GM-CSF Monoclonal antibody specifically detects GM-CSF in Human samples. It is validated for Flow Cytometry,ELISA,Functional AssaySpecifications
| GM-CSF | |
| Flow Cytometry, ELISA, Functional Assay | |
| Unconjugated | |
| Human | |
| Biologically Active Proteins, Cytokine Research, Immunology | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| colony stimulating factor 2 (granulocyte-macrophage), Colony-stimulating factor, CSF, GM-CSF, GMCSFgranulocyte-macrophage colony-stimulating factor, granulocyte-macrophage colony stimulating factor, MGC131935, MGC138897, molgramostin, sargramostim | |
| CSF2/ GM-CSF | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. |
| otilimab | |
| Monoclonal | |
| Purified | |
| RUO | |
| Human | |
| P04141 | |
| 1437 | |
| IgG1 | |
| Protein A purified | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title